[Percutaneous effect of O-( -hydoxyethyl)-rutosidea (HR)].
D000293:Adolescent; D000328:Adult; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects*; D001809:Blood Viscosity / Q000187:drug effects; D002196:Capillaries / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D003911:Dextrans / Q000494:pharmacology; D004074:Digitoxin / Q000494:pharmacology; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010946:Plants, Medicinal / Q000494:pharmacology; D011817:Rabbits; D012431:Rutin / Q000008:administration & dosage / Q000494:pharmacology*; D012867:Skin / Q000187:drug effects*; D012882:Skin Tests; D014648:Varicose Veins / Q000188:drug therapy; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D003911:Dextrans; D014662:Vasoconstrictor Agents; D012431:Rutin; D006493:Heparin; D004074:Digitoxin
Zur perkutanen Wirkung von O-( -Hydroxyäthyl)-Rutosidea (HR.